The year 2005 was an interesting one with regard to neurovascular disease. The results of the ISAT published in September indicate that the reduction in poor outcome is maintained up to 84 months. This obviously has to be weighed against the higher rebleed rate that is witnessed in the endovascular group. I am certain that this study will be the subject of considerable discussion at our upcoming meeting in February.

As the population with intracranial occlusive vascular disease continues to increase—this clearly is the largest population that our specialty must face—treatment of this disorder presents an exciting new frontier. With the development of intracranial stents and with lower risks associated with the techniques, the treatment of this disease will become more commonplace.

The challenges of training continue for the specialty of vascular neurosurgery and interventional neuroradiology. The collaboration between the CV Section and the ASITN continues to mature and strengthen. One exciting project that both organizations have been involved in over the past year is participation in the carotid registry, which will be multidisciplinary in nature. It is imperative that both of our organizations be key players in this registry along with our colleagues in vascular neurology.

The meeting in Orlando has been well thought out and planned by the ASITN and the CV Section leadership, and it promises to be an exciting event. We look forward to seeing you in February.